Sub menu

Vaccines

Havrix Junior

Details for Havrix Junior (hepatitis A) vaccine and its components.

Recently added

This page was added on 04 June 2018.

Updates made

This page was updated on [date-counter-updated-date]. View history of updates

Sponsor
GlaxoSmithKline Australia
Administration route
Intramuscular injection
Vaccine group
Monovalent vaccines
Description:

Registered for use in people aged 2–15 years.

Each 0.5 mL monodose vial or pre-filled syringe contains:

  • 720 ELISA units of inactivated hepatitis A virus (HM175 strain)
  • 0.25 mg aluminium as aluminium hydroxide hydrate

Also contains traces of:

  • formaldehyde
  • neomycin
  • polysorbate 20

For Product Information and Consumer Medicine Information about Havrix Junior visit the Therapeutic Goods Administration website.

Additional vaccine information

For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.

Related diseases
Hepatitis A

Page history

Last updated
Last reviewed

Help us improve the Australian Immunisation Handbook

Printed content may be out of date. For up to date information, always refer to the digital version:

https://immunisationhandbook.health.gov.au/vaccines/havrix-junior

All vaccines

Link copied

Link, share or bookmark directly to this section of the page.